Dr. Natalie Yivgi-Ohana, Ph.D. - CEO, Minovia Therapeutics - Harnessing The Therapeutic Power Of Mitochondria

Send us Fan MailDr. Natalie Yivgi-Ohana, Ph.D. is Co-Founder and CEO of Minovia Therapeutics ( https://minoviatx.com/ ), a biotech company dedicated to rapidly advance life-changing therapies that address the unmet need of serious and complex mitochondrial diseases, and are the first clinical-stage company to develop a mitochondrial transplantation approach to treat a broad range of indications generated by a mitochondrial dysfunction which lead to rare-genetic or age-related diseases.Dr. Yivgi-Ohana has twenty years of experience in mitochondrial research and received her Ph.D. in Biochemistry at The Hebrew University, after which she completed her postdoctoral fellowship at the Weizmann Institute of Science. Dr. Yivgi-Ohana also has her B.Sc., Medical Sciences Ben-Gurion University of the Negev and her Master’s Degree, Human Reproduction Bar-Ilan University. Dr. Yivgi-Ohana founded Minovia with a passion to help children and adults with mitochondrial diseases worldwide.#NatalieYivgiOhana #MinoviaTherapeutics #MitochondrialDysfunction #Mitochondria #ATPProduction #MetabolicRegulation #CalciumHandling #Redox #Balance #CellFateDecisions #Heteroplasmy #ThresholdEffect #MitochondrialAugmentationTechnology #PearsonSyndrome #KearnsSayreSyndrome #LowRiskMyelodysplasticSyndrome #SyngeneicMaternalMitochondria #AllogeneicMitochondria #Bioenergetics #Aging #Healthspan #Lifespan #Longevity #Israel #Geroscience #RareDiseases #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show